Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

BGXX Bright Green Corporation

0,1481

0,00 (0,00%)

Zuletzt aktualisiert: 01:00:00

Verzögert um 15 Minuten

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Bright Green (NASDAQ:BGXX)
Historical Stock Chart
Von Nov 2024 bis Dez 2024

Click Here for more Bright Green Charts.

Bright Green (NASDAQ:BGXX)
Historical Stock Chart
Von Dez 2023 bis Dez 2024

Click Here for more Bright Green Charts.

News Bright Green Corporation

LYNN STOCKWELL ENTERS INTO A RESTRUCTURING SECURITY AGREEMENT (“RSA”) WITH BRIGHT GREEN CORPORATION AND ASSUMES THE ROLE OF EXECUTIVE CHAIR AND CEO.
Freitag 27 Dezember 2024 (3 Tage vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 19 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 18 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Bright Green Corporation Provides an Update, Reinforces Commitment to Shareholders, and Focuses on Growth and Strategic Partnerships
Donnerstag 19 September 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 18 September 2024 (3 Monate vor) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Mittwoch 18 September 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Montag 9 September 2024 (4 Monate vor) • Edgar (US Regulatory)

BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA OPERATIONS, LLC. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY.
Freitag 23 August 2024 (4 Monate vor) • GlobeNewswire Inc.

BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA PHARMACEUTICALS. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY.
Mittwoch 21 August 2024 (4 Monate vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 19 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 19 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Bright Green Corporation News-Artikel

Invesco QQQ Trust Series 1

Euro vs US Dollar

Deutsche Lufthansa

Gold vs US Dollar

BNP Paribas (QX)

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen